Pharmaceutical compounding and storage of faricimab in a syringe for intravitreal injection do not impair stability and bi-specific binding properties.
Jørstad Ø.K, Foss S, Gjølberg T.T, Mester S, Nyquist-Andersen M, Sivertsen M.S, Fossum D, Gleditsch E, Moe M.C, Andersen J.T. (OEYJOE@ous-hf.no)
Int J Retina Vitreous - 2023 - ; 9:65.